CAR T-Cell Therapy: A Path of Hope and Healing

This docuseries was created to to inform blood cancer patients, caregivers, healthcare providers, and the public about the revolutionary progress of chimeric antigen receptor (CAR) T-cell therapy. 

Through an array of emotional patient stories and an interview with immunologist and oncologist Carl June, MD, of Penn Medicine, this 3-part mini-series highlights the advancements in blood cancer treatment, specifically in CAR T-cell and other cellular therapies.

Dr. June helped pioneer CAR T-cell therapy through LLS-funded research.

Speakers

Carl June, MD
Cancer Researcher & CAR T-cell Therapy Pioneer
Richard W. Vague Professor in Immunotherapy
Professor of Medicine
Director, Center for Cellular Immunotherapies
Director, Parker Institute for Cancer Immunotherapy
University of Pennsylvania Perelman School of Medicine

Maurice
Multiple Myeloma Patient

Tim 
Diffuse Large B-Cell Lymphoma
CAR T-Cell Therapy Patient

Supporters

Support provided by Kite, a Gilead Company; Bristol Myers Squibb; Johnson & Johnson and Legend Biotech.